BNP in the diagnosis and risk stratification of heart failure

Gordon W Moe1

  • 1Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.

Heart Failure Monitor
|October 20, 2005
PubMed

Insights

Brain natriuretic peptide (BNP) and NT-proBNP are valuable biomarkers for diagnosing heart failure (HF) and predicting patient outcomes. Testing these peptides can aid in HF diagnosis and management.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Research

Background:

  • Heart failure (HF) presents diagnostic challenges with conventional methods.
  • Cardiac natriuretic peptides, like BNP, are crucial biomarkers for cardiac function.
  • BNP and NT-proBNP are linked to HF diagnosis, prognosis, and mortality.

Purpose of the Study:

  • To highlight the diagnostic and prognostic utility of BNP and NT-proBNP in heart failure.
  • To discuss the role of natriuretic peptides in cardiovascular disorders.
  • To explore the potential of BNP/NT-proBNP testing in optimizing HF management.

Main Methods:

  • Observational studies establishing associations between plasma BNP/NT-proBNP and HF.
  • Analysis of preliminary data from randomized controlled trials on biomarker-guided therapy.
  • Consideration of confounding variables in biomarker interpretation.

Main Results:

  • Plasma BNP and NT-proBNP levels strongly correlate with HF diagnosis.
  • These biomarkers independently predict mortality and HF events.
  • Preliminary trial data suggest BNP/NT-proBNP levels can optimize HF patient management.

Conclusions:

  • BNP and NT-proBNP are essential tools for HF diagnosis and prognosis.
  • Careful clinical application of these biomarkers is highly beneficial.
  • Ongoing large-scale trials will further define the role of BNP/NT-proBNP-guided HF therapy.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...